基本信息 产品详情 公司简介 推荐产品
网站主页 PAK-3, HUMAN, 重组蛋白 (HIS) PAK-3, Human, 重组蛋白 (His)
  • PAK-3, Human, 重组蛋白 (His)|TMPY-04397|TargetMol

PAK-3, Human, 重组蛋白 (His)|TMPY-04397|TargetMol

PAK-3 Protein, Human, Recombinant (His)
1930 20μg 起订
上海 更新日期:2026-05-08

TargetMol 中国(陶术生物)

VIP1年
联系人:邵经理
电话:400-821-0310拨打
手机:15002144251 拨打
邮箱:xuexiang.shao@tsbiochem.com

产品详情:

中文名称:
PAK-3, Human, 重组蛋白 (His)
英文名称:
PAK-3 Protein, Human, Recombinant (His)
品牌:
TargetMol
产地:
美国
保存条件:
Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months Shipping with blue ice/Shipping at ambient temperature.
产品类别:
抑制剂
货号:
TMPY-04397

Product Introduction

Bioactivity

名称PAK-3 Protein, Human, Recombinant (His)
描述PAK3 is a member of PAK proteins, a family of serine/threonine p21-activating kinases, serve as effectors of small Rho GTPases Cdc42 and RAC and have been implicated in a wide range of biological activities. There are six mammalian PAKs which can be divided into two groups: group I PAKs (PAK1-3) and group II PAKs (PAK4-6). Although the two PAK groups are architecturally similar there are differences in their mode of regulation suggesting their cellular functions are likely to be different. Group I p21-activated kinases (PAK1/2/3) is demonstrated as ERK3/ERK4 activation loop kinases. It has been shown that group I PAKs phosphorylate ERK3 and ERK4 on Ser-189 and Ser-186, respectively, both in vitro and in vivo, and that expression of activated Rac1 augments this response. Besides regulation enzymatic activation of ERK3/ERK4, PAKs can also play roles in downstream activation of MAP kinase-activated protein kinase 5 (MK5) in vivo. Thus, the group I PAKs act as upstream activators of ERK3 and ERK4 and unravel a novel PAK-ERK3/ERK4-MK5 signaling pathway. In clinical, PAK has been proposed as a potential therapeutic target in schwannomas.
存储条件Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months Shipping with blue ice/Shipping at ambient temperature.
关键字OPHN-3 | OPHN 3 | MRX-47 | MRX-30 | MRX 47 | MRX 30
br
PAK3β|||PAK3beta|||p21 protein (Cdc42/Rac)-activated kinase 3|||OPHN3|||MRX47|||MRX30|||hPAK3|||CDKN1A|||bPAK|TargetMol

公司简介


成立日期 (14年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生物化工,化学试剂,生物技术服务

PAK-3, Human, 重组蛋白 (His)相关厂家报价

内容声明
拨打电话 立即询价